R&D in the Pharmaceutical Industry: A World of Small Innovations

  title={R&D in the Pharmaceutical Industry: A World of Small Innovations},
  author={Juan-Jos{\'e} Ganuza and Gerard Llobet and Beatriz Dom{\'i}nguez},
  journal={Management Science},
It is commonly argued that in recent years pharmaceutical companies have directed their R&D towards small improvements of existing compounds instead of more risky drastic innovations. In this paper we show that this bias towards small innovations is likely to be linked to the lack of market sensitivity of a part of the demand to changes in prices. Compared to their social contribution, small innovations are relatively more profitable than large ones because they are targeted to inelastic… CONTINUE READING

From This Paper

Figures, tables, and topics from this paper.
5 Citations
24 References
Similar Papers


Publications referenced by this paper.
Showing 1-10 of 24 references

Patent Expiration, Entry and Competition in the U.S. Pharmaceutical Industry,

  • Caves, R.E, M. D. Whinston, M. A. Hurwitz
  • Brookings Papers on Economic Activity,
  • 1991
Highly Influential
6 Excerpts

Scott-Morton, “The Distortionary Effects of Government Procurement: Evidence from Medicaid Prescription Drug Purchasing,

  • Duggan, Mark, M Fiona
  • Quarterly Journal of Economics ,
  • 2006

The Distortionary Effects of Government Procurement : Evidence from Medicaid Prescription Drug Purchasing

  • Mark Duggan, Fiona M. Scott-Morton
  • Quarterly Journal of Economics
  • 2006
1 Excerpt

Bargains and Ripoffs : A Model of Monopolistically Competitive Price Dispersion

  • Joseph E Stiglitz
  • Review of Economic Studies
  • 2004

Keuffel, “Regulation of the Pharmaceutical Industry,

  • Danzon, M Patricia, Eric
  • 2004

Price Controls and the Evolution of Pharmaceutical Markets,

  • Hassett, A Kevin
  • 2004

Similar Papers

Loading similar papers…